Proposed algorithm to investigate latent and occult viruses in vaccine cell substrates by chemical induction.
The recent urgency to develop new vaccines for emerging and re-emerging diseases, such as pandemic influenza, has necessitated the use of cell substrates not previously used in the manufacture of licensed vaccines. A major safety concern in the use of novel cell substrates is the presence of potential adventitious agents, such as latent and occult viruses, that may not be detected by currently used conventional assays. In cases where the novel cell substrate is known to be tumorigenic, there are additional safety issues related to tumorigenicity of intact cells and oncogenicity of residual cellular DNA. We have developed a strategy for evaluating vaccine cell substrates for the presence of latent/occult viruses, including endogenous retroviruses, latent RNA viruses and oncogenic DNA viruses, by optimizing conditions for chemical induction of viruses and using a combination of broad and specific assays to enable detection of known and novel viruses.
Khan
Arifa S
AS
Laboratory of Retrovirus Research, Center for Biologics, Evaluation and Research, US Food and Drug Administration, Bethesda, MD 20892, USA. arifa.khan@fda.hhs.gov
Ma
Wenbin
W
Ma
Yunkun
Y
Kumar
Anita
A
Williams
Dhanya K
DK
Muller
Jacqueline
J
Ma
Hailun
H
Galvin
Teresa A
TA
D000465:Algorithms; D014612:Vaccines; D014780:Viruses / Q000302:isolation & purification*
D014612:Vaccines